It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A new study into the potential health hazards of the revolutionary nano-sized particles known as 'buckyballs' predicts that the molecules are easily absorbed into animal cells, providing a possible explanation for how the molecules could be toxic to humans and other organisms. These curious soccer ball-shaped molecules can invade cell membranes, according to the new study of carbon-60 toxicity.
In recent years, much research has focused on the potential health and environmental impacts of buckyballs and carbon nanotubes. Fullerenes have been shown to cause brain damage in fish and inhaling carbon nanotubes results in lung damage similar to that caused by asbestos.
originally posted by: ontarff
a reply to: StallionDuck
Please cite the URL of the study. I believe it was a study conducted with fullerenes produced using solvents. The remnant solvents can cause harm.
Here is another Youtube link to new information. Bob Greska on Youtube
Abstract Here we review fullerenes biological effects focusing on their antioxidant and anti-ageing action. A scope of various poisonous and healing properties reported in literature for fullerene and its derivatives is analyzed. The review begins with the history of fullerenes discovery and their main properties. Then we focus on the longevity and antioxidant action, including the confrontation of available experimental data and theoretical modeling of buckminsterfullerene C60. Special attention is given to our hypothesis concerning the possibility of fullerenes to act as mitochondria protonophore and various simulations of the transport of C60 and its hydroxylated and other derivatives through lipid bilayer membranes, which can account for scavenging capacity of fullerenes for reactive oxygen species and their acting as mild mitochondrial respiration uncouplers. Extension of the theoretical modeling to the mitochondria membranes and implications on the real biological systems is analyzed. Finally, we focus on the toxicity evaluation and current therapeutic usage of fullerenes. The review contains a comprehensive discussion of both papers published by 2016 and our own research results.
"Thus, fullerene can be considered as a mitochondria-targeted antioxidant, worth further researching as a prospective component of novel medications."
These studies are mostly limited to in vitro and in vivo researches and have not reached the final stages of clinical trials yet. It is expected that, with the rapid technological advancement in this field, this trend could change in the coming years so that the unique features of fullerenes could be exploited in clinical use. Although there are still major issues to overcome, the use of fullerenes for biomedical engineering will certainly have a bright future.